insulin isophane human and insulin human
| Brand name | Novolin 70/30 |
|---|---|
| Active ingredient | insulin isophane human and insulin human |
| Strength | 90UNITS/3ML (30UNITS/ML); 210UNITS/3ML (70UNITS/ML) |
| Dosage form | Injection |
| Route | Subcutaneous |
| Modality | Biologic |
| FDA approval | June 2018 |
| Marketing status | OTC |
Source: FDA Purple Book, layered on the CliffBio company graph. Cliff dates are the projected — 12-year biologic exclusivity estimate; estimates are projections, not legal advice.